The impact of comorbidities on tumor necrosis factor inhibitor therapy in psoriatic arthritis: A population ‐based cohort study

ConclusionPresence of comorbidities was associated with higher baseline disease activity, shorter TNFi persistence and reduced clinical response rates in a cohort of Danish patients with PsA.This article is protected by copyright. All rights reserved.

Source: Arthritis Care and Research - August 3, 2017 Category: Rheumatology Authors: Christine Ballegaard, Pil H øjgaard, Lene Dreyer, René Cordtz, Tanja Schjødt Jørgensen, Marie Skougaard, Simon Tarp, Lars Erik Kristensen Tags: Original Article Source Type: research